(1-Dimethylamino)allyl(η6-p-cymene)ruthenium diisopropylacetamidinate is expected to be synthesized as follows:
Dichloro(η6-p-cymene)ruthenium dimer is reacted with lithium diisopropylacetamidinate in THF at room temperature (approximately 25° C.) in a 3-neck round bottom flask which is equipped with magnetic or mechanical stirring and effective heating/cooling system to control the rate of reaction. After the mixture is stirred overnight at room temperature, (1-dimethylamino)allyl magnesium bromide is added at low temperature (approximately −30° C.). The resulting mixture is then stirred overnight under an inert atmosphere of nitrogen. The reagents are added in continuous and dropwise manner, and are allowed to mix slowly to control the exothermicity of the reaction. The crude product is then expected to separate from the reaction mass after filtration with a high yield expected. The target product is expected to be substantially free of organic solvents (<0.5 ppm) as determined by FT-NMR and also substantially free of metallic impurities (<10 ppb) as determined by ICP-MS/ICP-OES.
Bis(1-dimethylaminoallyl)bis(cyclopentadienyl)zirconium(IV) is expected to be synthesized as:
Dichloro bis(cyclopentadiene)zirconium is reacted with (1-dimethylamino)allyl magnesium bromide in THF at a low temperature (approximately −30° C.) in a 3-neck round bottom flask which is equipped with magnetic or mechanical stirring and effective heating/cooling system to control the rate of reaction. The mixture is stirred overnight at room temperature. The crude product is then expected to separate from the reaction mass after filtration with a high yield expected. The target product is expected to be substantially free of organic solvents (<0.5 ppm) as determined by FT-NMR and also substantially free of metallic impurities (<10 ppb) as determined by ICP-MS/ICP-OES.
Organometallic compounds of the formula (EDG-(CR1R2)y′—CR3═CR4—(CR5R6)y″)nM+mL1(m-n)L2p listed in the following table are expected to be prepared according to the procedures described in Examples 1 or 2.
In the above table, ligands separated by a comma denote that each ligand is present in that compound.
Compositions suitable for use in ALD or direct liquid injection processes are prepared by combining certain of the compounds of Example 3 with certain organic solvents. The particular compositions are shown in the following table. The organometallic compounds are typically present in a concentration of 0.1 M for direct liquid injection.
Number | Date | Country | |
---|---|---|---|
60834478 | Jul 2006 | US |